Supplements

Shaoyao Gancao Decoction as an adjunct to conventional Western medicine improves pain relief and sleep quality in patients with postherpetic neuralgia

This meta-analysis of 15 RCTs (1,188 patients) found that adding Shaoyao Gancao Decoction (SGD) to conventional Western medicine significantly improved overall response rate (OR=5.42, 95% CI: 3.40-8.64), reduced VAS pain scores (MD=-1.33, 95% CI: -1.68 to -0.99), improved PSQI sleep scores (MD=-2.23, 95% CI: -2.85 to -1.62), and reduced adverse events (OR=0.34, 95% CI: 0.21-0.56) compared to Western medicine alone.

Last updated: Aug 26, 2026โ€ข0 RCTsโ€ข1 Meta-analysesโ€ข๐Ÿ“– Read as article โ†’

Evidence Score

Evidence Score49/100
Human RCTโ˜†โ˜†โ˜†โ˜†โ˜†
Meta-analysisโ˜…โ˜…โ˜…โ˜†โ˜†
Mechanismโ˜…โ˜…โ˜…โ˜…โ˜…
Safetyโ˜…โ˜…โ˜…โ˜…โ˜†
Confidencelow

Study Evidence

Study 1. Shaoyao Gancao decoction for neuropathic pain: a systematic review and meta-analysis of postherpetic neuralgia.

observational

Zhao J, Wang F, Wang F, Ma L ยท American journal of translational research (2026)

Participants: N/A
Duration: 14 and 28 days (subgroup analysis)
Intervention: Shaoyao Gancao Decoction (SGD) added to conventional Western medicine
Outcome: Overall response rate, Visual Analogue Scale (VAS) pain score, Pittsburgh Sleep Quality Index (PSQI) score, adverse events, Pain Rating Index (PRI), Present Pain Intensity (PPI)
Effect Size: OR=5.42 for response rate; MD=-1.33 for VAS; MD=-2.23 for PSQI; OR=0.34 for adverse events
Population: Patients with postherpetic neuralgia (PHN), a subtype of neuropathic pain

Result:

Mechanism Graph

SGD contains active compounds (e.g., paeoniflorin, glycyrrhizin) with anti-inflammatory and analgesic properties
โ†“
These compounds may modulate neuropathic pain pathways, reducing central sensitization
โ†“
Improved pain control leads to better sleep quality and reduced pain-related sleep disturbance
โ†“
Result: Enhanced overall treatment response and reduced adverse events

Limitations

  • โš High heterogeneity observed in VAS analysis (I2=97%), though subgroup and sensitivity analyses suggested robustness
  • โš Only PHN subtype was analyzed; generalizability to other neuropathic pain types is uncertain
  • โš Potential publication bias not explicitly addressed in abstract
  • โš Duration of treatment varied (14 and 28 days), which may affect outcomes

Frequently Asked Questions

What is Shaoyao Gancao Decoction?โ–ผ

Shaoyao Gancao Decoction is a traditional Chinese herbal formula composed of Paeonia lactiflora (Shaoyao) and Glycyrrhiza uralensis (Gancao), used for pain relief.

How does SGD improve sleep in PHN patients?โ–ผ

By reducing neuropathic pain intensity (VAS score), SGD likely alleviates pain-related sleep disturbances, leading to improved PSQI scores.

Is SGD safe to use with conventional Western medicine?โ–ผ

The meta-analysis found a lower incidence of adverse events in the SGD group (OR=0.34), suggesting good safety as an adjunctive therapy.

Can SGD be used for other types of neuropathic pain?โ–ผ

The authors suggest potential value for other NP types (e.g., diabetic peripheral neuropathy), but further research is needed.

Products

Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.

References

  1. 1.Zhao J, Wang F, Wang F, Ma L. "Shaoyao Gancao decoction for neuropathic pain: a systematic review and meta-analysis of postherpetic neuralgia.." American journal of translational research, 2026. PMID: 42631154 DOI: 10.62347/AEVA1650
Disclaimer: This content is for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.